Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. These regulations govern how companies handle electronic shareholding through depositories such as NSDL and CDSL. The filing is a routine compliance disclosure confirming the company has met its obligations related to depository operations. No financial numbers, business updates, or strategic changes are mentioned in this announcement.
This is a routine regulatory compliance filing with no direct impact on the company's operations, financials, or shareholder value. Investors can treat it as a standard housekeeping disclosure.